Cipher Pharmaceuticals Inc
TSX:CPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
CA |
|
R
|
Rh Petrogas Ltd
SGX:T13
|
SG |
|
Kaga Electronics Co Ltd
TSE:8154
|
JP |
|
E
|
Empresas CMPC SA
SGO:CMPC
|
CL |
|
Naigai Co Ltd
TSE:8013
|
JP |
|
A
|
Aker Horizons ASA
OSE:AKH
|
NO |
|
F
|
FinecoBank Banca Fineco SpA
OTC:FCBBF
|
IT |
|
B
|
Bluebet Holdings Ltd
ASX:BBT
|
AU |
|
Texas Roadhouse Inc
NASDAQ:TXRH
|
US |
|
E
|
Euro Cervantes SOCIMI SA
MAD:YEUR
|
ES |
|
Abattis Bioceuticals Corp
OTC:ATTBF
|
CA |
|
T
|
Thai Wah PCL
SET:TWPC
|
TH |
|
T
|
Tomony Holdings Inc
TSE:8600
|
JP |
|
Prelude Therapeutics Inc
NASDAQ:PRLD
|
US |
Wall Street
Price Targets
CPH Price Targets Summary
Cipher Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
CPH
is 19.58 CAD
with a low forecast of 18.79 CAD and a high forecast of 21 CAD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CPH's stock price target?
Price Target
19.58
CAD
According to Wall Street analysts, the average 1-year price target for
CPH
is 19.58 CAD
with a low forecast of 18.79 CAD and a high forecast of 21 CAD.
What is Cipher Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
28%
For the last 13 years the
compound annual growth rate for
Cipher Pharmaceuticals Inc's revenue is
19%.
The projected
CAGR
for the next 3 years is
28%.
What is Cipher Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
68%
The
compound annual growth rate
of Cipher Pharmaceuticals Inc's operating income for the next 2 years is
68%.
What is Cipher Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
21%
The
compound annual growth rate
of Cipher Pharmaceuticals Inc's net income for the next 3 years is
21%.
